Annual Conference

The 2023 NCCN Annual Conference was held Friday, March 31 – Sunday, April 2, 2023, at the Orlando World Center Marriott and virtually.

View Press Coverage

Save the dates!

NCCN 2024 Annual Conference
Orlando World Center Marriott • Orlando, FL
Friday, April 5, 2024 – Sunday, April 7, 2024

Continuing Education

Conference attendees will have the opportunity to view conference sessions on-demand in the Virtual Event Platform through May 2023. Recorded presentations will be available on the NCCN Continuing Educational Portal, education.nccn.org, in June 2023.

Experts from leading cancer centers came together to discuss updates to NCCN Guidelines^®, the latest advances across several cancer types, and emerging issues in oncology.

CE credit was available for the oncology team. There were more than 30 live and on-demand educational sessions!

The agenda covered updates across a wide range of cancers including:

Bladder Cancer
Breast Cancer
Central Nervous System Cancers
CLL/SLL
Colorectal Cancer
Hepatobiliary Cancers
Multiple Myeloma
Non-Small Cell Lung Cancer
Ovarian, Fallopian Tube, and Primary Peritoneal Cancers
Prostate Cancer
Rectal Cancer
Renal Cell Carcinoma

Other sessions focused on issues in oncology and patient care:

Health Needs of the LGBTQ+ Community
Health System Recruitment and Retention
New Patient Access Programs
Patient Reported Outcomes
Reducing Admissions and Readmissions
Screening in Underrepresented Populations
Sexual Identity and Function
Sleep Disorder, Fatigue, and Cognitive Function
Social Determinants of Health

2023 Annual Conference Supporters

This activity is supported by educational grants from:

Astellas and Seagen
AstraZeneca
AVEO Pharmaceuticals, Inc. (“AVEO Oncology”)
BeiGene
Coherus BioSciences
Eisai
Exact Sciences
Fresenius Kabi USA, LLC
Genentech, a member of the Roche Group
GRAIL, LLC
GSK
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Lantheus
Lilly
Novartis
NOVOCURE
Olympus Corporation of the Americas
Puma Biotechnology
TerSera Therapeutics LLC.

This activity is supported by independent educational grants from:

AbbVie
Daiichi Sankyo
Gilead Sciences, Inc.
Incyte Corporation

This activity is supported by medical education grants from:

Exelixis, Inc.
Karyopharm Therapeutics

This project has been made possible in part by a grant from:

Varian Medical Systems, a Siemens Healthineers company /Global Medical Education Grant Program

This activity has been supported by an unrestricted educational grant from:

GE HealthCare, Pharmaceutical Diagnostics

This activity is supported by educational funding provided by:

Amgen

This activity is supported through an independent medical education grant from:

Merck & Co., Inc.

Supported by a grant from:

Pfizer Inc.

Exhibit Hall

The NCCN Exhibition Hall was held in-person and virtually for networking opportunities and to gather the latest information from industry-sponsored exhibits and more.

View Exhibit Guide

For exhibitor opportunities, contact Jennifer Tredwell, Vice President, NCCN Marketing and Communications.